期刊文献+

超广谱β-内酰胺酶的生物学特性及其检测的研究进展 被引量:5

在线阅读 下载PDF
导出
摘要 随着第三代头孢类抗生素如头孢噻肟、头孢曲松和头孢他啶在临床的广泛使用,细菌的耐药性不断加强,耐药机制日益复杂,
作者 王美英
出处 《河北医药》 CAS 2011年第17期2667-2669,共3页 Hebei Medical Journal
  • 相关文献

参考文献19

  • 1Bush K,Jacogy HA, Mederiros AA. A functional classitication scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995,39 : 1211-1233.
  • 2Goussard S, Ceourvalin PP. Uupdated sequence information for TEM lactamases genes. Antimiorerob Agents Chemother, 1999,43:367-370.
  • 3Bradford PA. Automated thermal cycling is superior to tradicional methods for nucleotide sequencing of blashv genes. Antimicrob Agents Chemother. 1999.43 : 2960 -2963.
  • 4Bonnet R, Dutour C, Sampaio JLM, et al. Novel cefotaximase ( CTX-M- 16) with increased catalytic efficiency due to substitution Asp-240. Gly Antimicrob AGENTS Chemother,2001,45 :2269-2275.
  • 5Poirel L, Girlich D, Nass T, et al. OXA-28, an extended-spectrum variant of OXA-10β-lactamase from pseudomonas aemginosa and its plasmid-and integron -located gene. Antimicrob Agents C hemother, 2001,45 : 447 -453.
  • 6Ouellette M, Bissonnette L, Roy PH. Precise insertion of antibiotic resistance determinants into Tn21-1ike transposons: nucleotide sequence of the OXA-1 lactamase of OXA-lactamase gene. Proc Ncatl Acad Sci USA, 1987,84:7378-7382.
  • 7Aubert D, Poirel L, Chevalier J, et al. Oxacilinase-mediated resistance to cefeoime and susceptibility to ceftazidime in Pseudomonas aeruginnosa. Antimicrob Agenls Chemother,2001,45 : 1615-1620.
  • 8Aubert D,Poirel L, Ali AB, et al. OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginoa J Antimicrob Chemother,2001,48: 717-721.
  • 9Yagi T, Kurokawa H, Shibata N, et al. A preliminary survey of extended spectrum beta- lactamases ( ESBLs ) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett,2000, 184:53-56.
  • 10孙景勇,倪语星.大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶的基因分型[J].中国抗感染化疗杂志,2002,2(4):211-214. 被引量:50

二级参考文献30

  • 1夏培元,肖光夏.细菌对抗生素的耐药性—— 一个必须面对的严重问题[J].中华烧伤杂志,2001,17(2):7-10. 被引量:24
  • 2季淑娟,陈亚岗,俞云松,周伟琳,李家斌,李兰娟.浙江省产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的基因分型[J].中华传染病杂志,2005,23(2):75-78. 被引量:57
  • 3徐元宏,沈继录,周强,杨佰侠,李涛,盛大平,王中新.蚌埠地区CTX-M型超广谱β内酰胺酶的检测[J].中华检验医学杂志,2007,30(2):204-205. 被引量:3
  • 4Lewis JS 2nd, Herrera M, Wickes B,et al. First report of the emergence of CTX M type extended beta-spectrum laetamases (ESBLs) as the predominant ESBL isolated in a U. S. health care system[J]. Antimierob Agents Chemother,2007, 51(11):4015-4021.
  • 5Machado E, Coque TM, Canton R,et al. High diversity of extended-spectrum beta lactamases among clinical isolates of Enterobacteriaceae from Portugal[J]. J Antimicrob Chemother,2007,60(6) : 1370- 1374.
  • 6Hernandez JR, Martinez Martinez L,Canton R,et al. Nationwide study of Esckerichia coli and Klebsiella pneumoniae producing extended spectrum β-lactamases in Spain[J]. J Antimicrob Chemother, 2005,49 ( 5 ) : 2122-2125.
  • 7Edelstein M, Pimkin M, Palagin I,et al. Prevalence and Molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals [J]. Antimicrob Agents Chemother, 2003,47(12) 3724 -3732.
  • 8Ryoo NH,Kim EC,Hong SG,et al. Dissemination of SHV- 12and CTX-M-type extended spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES 3 in Korea[J]. J Antimicrobial Chemotherapy,2005,56(4) : 698-702.
  • 9Yagi T, Kurokawa H, Shibate N, et al. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolares of Klebsiella pneumoniae and Escherichia coli in Japan [J]. FEMS Microbiol Lett, 2000,184(1): 53 -56.
  • 10叶素娟,杨青,俞云松.2005年中国CHINET大肠埃希菌和肺炎克雷伯菌耐药性分析[J].中国感染与化疗杂志,2007,7(4):283-286. 被引量:73

共引文献102

同被引文献49

  • 1陈晓飞,邓敏,曾吉,杨汉菊.7016株临床分离病原菌耐药性分析[J].中华医院感染学杂志,2006,16(4):460-462. 被引量:13
  • 2毛盛尧,朱幼珠,张翊.医院感染常见非发酵革兰阴性菌的临床分布和耐药性分析[J].中华医院感染学杂志,2006,16(6):694-696. 被引量:55
  • 3余奇松,郭世辉,黄小红,朱莲娜,韦惠茹,梁宏洁,农加根.产超广谱β-内酰胺酶大肠埃希菌与肺炎克雷伯菌耐药性分析[J].中华医院感染学杂志,2007,17(7):878-880. 被引量:33
  • 4邓旭,高赟,张艳,王素梅.临床标本细菌分布及耐药性分析[J].中华医院感染学杂志,2007,17(7):888-890. 被引量:28
  • 5Paterson DL, Bonomo RA. Extended-spectrum beta- lactamases: a clinical update[J]. Clin Microbiol Rev, 2005,18(4) .- 657-686.
  • 6Lahey Clinic. [3-Lactamase classification and amino a- cid sequences for TEM, SHV and OXA extended- spectrum and inhibitor resistant enzymes[EB/OL] http ://www. lahey, org/studies/webt, htm, 2001.
  • 7Gniadkowski M, Schneider I, Patucha A, et al. Cefo- taxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme [J]. Antimicrobial Agents and Chemotherapy, 1998, 42(4):827-832.
  • 8Yan J J, Ko WC, Tsai SH, et al. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan[J]. Journal of Clinical Microbiology, 2000,38 (12) .- 4320-4325.
  • 9De Champs C,Sirot D,Chanal C,et al. A 1998 survey of extended-spectrum beta-lactamases in Enterobac- teriaceae in France. The French Study Group[J]. An- timicrob Agents Chemother, 2000, 44 ( 11 ) : 3177- 3179.
  • 10Bonnet R. Growing Group of Extended-spectrum /3- Lactamases: the CTX-M enzymes[J]. Antimicrob A- gents Chemother,2004,48(1) : 1-14.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部